Publications by authors named "Michael Ermisch"

Claim this Profile
A
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.
Elaine Julian, Tom Belleman, Maria João Garcia, Maureen Rutten-van Mölken, Robin Doeswijk, Michael Ermisch

J Mark Access Health Policy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Michael Ermisch

Appl Health Econ Health Policy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P Martin, Jesper Van Den Bergh

Front Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau

Front Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimerization of human 5-lipoxygenase.
Ann-Kathrin Häfner, Mihaela Cernescu, Bettina Hofmann, Michael Ermisch, Michael Hörnig

Biol Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase A activates and phosphorylates RORα4 in vitro and takes part in RORα activation by CaMK-IV.
Michael Ermisch, Beate Firla, Dieter Steinhilber

Biochem Biophys Res Commun· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis